Breaking News Instant updates and real-time market news.

MRK

Merck

$62.84

-0.26 (-0.41%)

06:01
08/08/17
08/08
06:01
08/08/17
06:01

Merck says NICE recommends Erbitux/platinum-based chemotherapy combination

Merck announced that the National Institute for Health and Care Excellence, or NICE, for England has issued a positive Final Appraisal Determination, or FAD, recommending the routine National Health Service, or NHS, use of Erbitux in combination with platinum-based chemotherapy as a first-line therapy for the treatment of patients with recurrent and/or metastatic, or R/M, squamous cell carcinoma of the head and neck, or SCCHN, in the oral cavity. NICE's decision confirms the positive benefit Erbitux can have on the survival of patients in this setting. Erbitux is already established and reimbursed as an effective therapy for different stages of SCCHN across many countries worldwide.

  • 28

    Aug

  • 22

    Sep

MRK Merck
$62.84

-0.26 (-0.41%)

07/28/17
RHCO
07/28/17
NO CHANGE
RHCO
Merck, AstraZeneca deal positive, says SunTrust
After Merck (MRK) paid $1.6B upfront for access to Astrazeneca's (AZN) PARP inhibitor, Lynparza and another drug, SunTrust analyst John Boris says that the deal "makes strategic/financial sense and validates the PARP inhibitor class." He adds that the companies are "ideally positioned" to leverage a combination of IO and PARP therapies. The analyst reiterates a $73 price target and a Buy rating on Merck.
07/27/17
JANY
07/27/17
NO CHANGE
Target $107
JANY
Buy
PARP deals may make Clovis more attractive buyout candidate, says Janney
The partnerships announced today between AstraZeneca (AZN) and Merck (MRK) as well as Tesaro (TSRO) and Takeda highlight pharma's willingness to expand on PARP's, Janney analyst Debjit Chattopadhyay tells investors in a research note. Clovis' (CLVS) Rubraca is now the only unencumbered PARP and is "far cheaper" on a relative valuation basis than peer Tesaro, the analyst adds. He believes Clovis could now become a more compelling takeover candidate. Chattopadhyay has a Buy rating on the shares with a $107 price target. The stock in midday trading is up 7%, or $5.90, to $93.33.
07/27/17
FBCO
07/27/17
NO CHANGE
FBCO
Merck unlikely to buy PARP company after Astra deal, says Credit Suisse
Credit Suisse analyst Alethia Young believes Merck (MRK) is unlikely to acquire a PARP inhibitor company like Tesaro (TSRO) or Clovis (CLVS) after inking an immuno-oncology deal with AstraZeneca (AZN).
07/27/17
GSCO
07/27/17
NO CHANGE
GSCO
Merck could trade up $5 following AstraZeneca MYSTIC failure, says Goldman Sachs
Goldman analyst Jami Rubin expects Merck (MRK) to trade up approximately $5 based on sentiment following AstraZeneca's MYSTIC failure as it partially de-risks longer-term estimates for Keytruda. As a result, the analyst raised Merck's Keytruda sales estimates by $600M in 2018 and $1B in 2019 and beyond, increasing earnings estimates by 14c-20c, and raising his price target on shares to $74 from $70. Rubin cautions that long-term estimates could be at risk if other competitor trials are successful. The analyst rates Merck a Neutral.

TODAY'S FREE FLY STORIES

CRON

Cronos Group

$14.14

2.57 (22.21%)

11:25
09/19/18
09/19
11:25
09/19/18
11:25
Options
Cronos Group call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:25
09/19/18
09/19
11:25
09/19/18
11:25
Conference/Events
RBC Capital hardware analyst to hold a group luncheon »

Hardware & Semis…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
09/19/18
09/19
11:17
09/19/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
09/19/18
09/19
11:16
09/19/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,911.33

-29.87 (-1.54%)

11:14
09/19/18
09/19
11:14
09/19/18
11:14
Periodicals
EU antitrust regulator looking at Amazon's use of merchant data, Reuters reports »

The EU's competition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAO

Nordic American Offshore

$0.94

-0.015 (-1.58%)

11:11
09/19/18
09/19
11:11
09/19/18
11:11
Hot Stocks
Nordic American Offshore announces receipt of notice from NYSE »

Nordic American Offshore…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$40.68

0.37 (0.92%)

11:00
09/19/18
09/19
11:00
09/19/18
11:00
Options
Repeat put buying in Chemours Company »

Repeat put buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$84.55

-0.48 (-0.56%)

, TCEHY

Tencent

$0.00

(0.00%)

10:59
09/19/18
09/19
10:59
09/19/18
10:59
Periodicals
Novartis, Tencent to partner, focus on cardiovascular disease, Bloomberg says »

Bloomberg cites an email…

NVS

Novartis

$84.55

-0.48 (-0.56%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

UNP

Union Pacific

$162.66

-1.04 (-0.64%)

10:58
09/19/18
09/19
10:58
09/19/18
10:58
Recommendations
Union Pacific analyst commentary  »

Union Pacific call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 06

    Nov

PDD

Pinduoduo

$23.56

0.92 (4.06%)

10:55
09/19/18
09/19
10:55
09/19/18
10:55
Options
Pinduoduo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:50
09/19/18
09/19
10:50
09/19/18
10:50
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

10:45
09/19/18
09/19
10:45
09/19/18
10:45
General news
El-Erian hinting at further yield rise implications »

El-Erian hinting at…

10:45
09/19/18
09/19
10:45
09/19/18
10:45
Hot Stocks
Breaking Hot Stocks news story  »

SilverCrest Metals Inc…

10:40
09/19/18
09/19
10:40
09/19/18
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

AN

AutoNation

$44.15

1.06 (2.46%)

, GM

General Motors

$35.69

0.58 (1.65%)

10:38
09/19/18
09/19
10:38
09/19/18
10:38
Hot Stocks
AutoNation CEO Jackson to step down in 2019 after nearly 20 years »

Shares of AutoNation (AN)…

AN

AutoNation

$44.15

1.06 (2.46%)

GM

General Motors

$35.69

0.58 (1.65%)

F

Ford

$9.79

0.205 (2.14%)

BRK.A

Berkshire Hathaway

$329,890.01

2310.01 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

GS

Goldman Sachs

$232.76

3.81 (1.66%)

, JPM

JPMorgan

$116.50

2.15 (1.88%)

10:37
09/19/18
09/19
10:37
09/19/18
10:37
Periodicals
Goldman nearing deal to spin off fintech app 'Simon,' WSJ reports »

Goldman Sachs (GS) is in…

GS

Goldman Sachs

$232.76

3.81 (1.66%)

JPM

JPMorgan

$116.50

2.15 (1.88%)

HSBC

HSBC

$44.01

0.72 (1.66%)

BCS

Barclays

$9.26

0.155 (1.70%)

WFC

Wells Fargo

$55.06

0.555 (1.02%)

CS

Credit Suisse

$15.30

0.21 (1.39%)

PRU

Prudential

$102.38

2.16 (2.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 21

    Oct

  • 26

    Feb

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

MRVL

Marvell

$18.60

-0.06 (-0.32%)

10:37
09/19/18
09/19
10:37
09/19/18
10:37
Conference/Events
Marvell management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

10:37
09/19/18
09/19
10:37
09/19/18
10:37
Conference/Events
Morgan Stanley multi-industrial analysts hold analyst/industry conference call »

U.S. Electrical Equipment…

INO

Inovio

$4.87

0.01 (0.21%)

10:36
09/19/18
09/19
10:36
09/19/18
10:36
Conference/Events
Inovio management to meet with Piper Jaffray »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

XYF

X Financial

$0.00

(0.00%)

10:36
09/19/18
09/19
10:36
09/19/18
10:36
Syndicate
Breaking Syndicate news story on X Financial »

X Financial opens at $15,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

10:35
09/19/18
09/19
10:35
09/19/18
10:35
General news
Crude inventories for week of September 14 »

Crude oil inventories…

SPY

SPDR S&P 500 ETF Trust

$290.95

-0.01 (-0.00%)

, SPX

S&P 500

$0.00

(0.00%)

10:32
09/19/18
09/19
10:32
09/19/18
10:32
General news
New NAFTA deal with Canada unlikely to be reached this week, Bloomberg says »

A new NAFTA deal between…

SPY

SPDR S&P 500 ETF Trust

$290.95

-0.01 (-0.00%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$5.86

0.06 (1.03%)

, HUM

Humana

$336.41

0.57 (0.17%)

10:31
09/19/18
09/19
10:31
09/19/18
10:31
Hot Stocks
Fitbit in focus amid expanded strategic partnership with Humana »

Shares of smartband and…

FIT

Fitbit

$5.86

0.06 (1.03%)

HUM

Humana

$336.41

0.57 (0.17%)

AAPL

Apple

$215.54

-2.7 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

WMT

Walmart

$95.72

0.29 (0.30%)

, JSAIY

J Sainsbury

$0.00

(0.00%)

10:30
09/19/18
09/19
10:30
09/19/18
10:30
Hot Stocks
U.K. regulator refers Sainsbury acquisition of Asda for in-depth investigation »

In August, the…

WMT

Walmart

$95.72

0.29 (0.30%)

JSAIY

J Sainsbury

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

  • 03

    Mar

FIT

Fitbit

$5.87

0.07 (1.21%)

, HUM

Humana

$336.41

0.57 (0.17%)

10:29
09/19/18
09/19
10:29
09/19/18
10:29
Recommendations
Fitbit, Humana analyst commentary  »

Fitbit launch of…

FIT

Fitbit

$5.87

0.07 (1.21%)

HUM

Humana

$336.41

0.57 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.